paromomycin has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baruffini, E; Burlina, AB; Dallabona, C; Ferrero, I; Ghezzi, D; Haack, TB; Invernizzi, F; Meitinger, T; Melchionda, L; Parini, R; Prokisch, H; Strom, TM; Zeviani, M | 1 |
1 other study(ies) available for paromomycin and Cardiomyopathy, Hypertrophic
Article | Year |
---|---|
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis.
Topics: Acidosis, Lactic; Base Sequence; Cardiomyopathy, Hypertrophic; Carrier Proteins; DNA Mutational Analysis; DNA, Mitochondrial; Fibroblasts; Homozygote; Humans; Mitochondria; Molecular Sequence Data; Mothers; Mutation; Mutation, Missense; Nucleic Acid Conformation; Oxidative Phosphorylation; Paromomycin; Phenotype; Phosphorylation; Respiration; RNA-Binding Proteins; RNA, Ribosomal; RNA, Transfer; Saccharomyces cerevisiae | 2012 |